~~<i id='E83AF3F9CB'><strike id='E83AF3F9CB'><tt id='E83AF3F9CB'><pre id='E83AF3F9CB'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

author：leisure time 2025-10-02 11:20:33 Page View：3212

Biotech and life sciences investors continue to draw in new funds even as the biotech stock indexes reach new lows.

On Wednesday, VC firm Bioluminescence Ventures launched with $477 million to invest in biotech startups. The firm was founded by Kouki Harasaki, who was previously a partner at M12, Microsoft’s corporate venture group, and Andreessen Horowitz. He also has a track record at pharmaceutical companies like Novartis and Baxalta.

Bioluminescence joined at least four other firms — OrbiMed, Sofinnova Partners, Abingworth, and Revelation Partners — in announcing new pools of capital in the last two weeks. Together, they have raised $5.94 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： John Green on his newest strategy for fighting tuberculosis
Next article： Bright Health sells Medicare Advantage business to Molina

focus

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

Think you might have Covid

AdobeIfyouhaveacough,fever,orshortnessofbreath,howcanyoutellifyou’vegotCovid-19,acommoncold,theordin

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

Parkinson’s finding may lead to tests and, someday, treatments

CourtesyMarkSeligerNEWYORK— MichaelJ.FoxwassittinginhisUpperEastSideofficesurroundedbyEmmysandanOsca